Hirsch David 4
4 · RAPID MICRO BIOSYSTEMS, INC. · Filed Jul 20, 2021
Insider Transaction Report
Form 4
Hirsch David
Director10% Owner
Transactions
- Conversion
Common Stock Warrant
2021-07-19+129,032→ 129,032 total(indirect: Held by Longitude Venture Partners II, L.P.)Exercise: $0.05Exp: 2028-01-17→ Class A Common Stock (129,032 underlying) - Conversion
Series C1 Preferred Stock
2021-07-19−2,291,665→ 0 total(indirect: Held by Longitude Venture Partners II, L.P.)→ Class A Common Stock (458,333 underlying) - Conversion
Series A1 Warrant
2021-07-19−2,500,000→ 0 total(indirect: Held by Longitude Venture Partners II, L.P.)Exercise: $0.01Exp: 2027-07-24→ Series A1 Preferred Stock (2,500,000 underlying) - Conversion
Class A Common Stock
2021-07-19+3,344,038→ 3,407,952 total(indirect: Held by Longitude Venture Partners II, L.P.) - Conversion
Series A1 Preferred Stock
2021-07-19−8,774,007→ 0 total(indirect: Held by Longitude Venture Partners II, L.P.)→ Class A Common Stock (1,754,801 underlying) - Conversion
Common Stock Warrant
2021-07-19+500,000→ 500,000 total(indirect: Held by Longitude Venture Partners II, L.P.)Exercise: $0.05Exp: 2027-07-24→ Class A Common Stock (500,000 underlying) - Conversion
Series B1 Preferred Stock
2021-07-19−5,654,529→ 0 total(indirect: Held by Longitude Venture Partners II, L.P.)→ Class A Common Stock (1,130,904 underlying) - Conversion
Series B1 Warrant
2021-07-19−645,160→ 0 total(indirect: Held by Longitude Venture Partners II, L.P.)Exercise: $0.01Exp: 2028-01-17→ Series B1 Preferred Stock (645,160 underlying)
Footnotes (4)
- [F1]The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the "Preferred Stock") are convertible at any time, at the holder's election and have no expiration date. Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering.
- [F2]The securities are held directly by Longitude Venture Partners II, L.P. ("LVP II"). Longitude Capital Partners II, LLC ("LCP II"), the general partner of LVP II, may be deemed to have voting and investment power with respect to the shares held by LVP II. The Reporting Person is a member of LCP II and may be deemed to share voting and investment power over the shares of the issuer held by LCP II. LCP II and Dr. Hirsch disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein.
- [F3]The Issuer's Preferred Stock warrants automatically converted into warrants to purchase Common Stock immediately prior to the closing of the Issuer's initial public offering without payment or further consideration. The transaction is listed solely for the purpose of reporting the change in the shares underlying the warrants.
- [F4]Immediately exercisable.